» Articles » PMID: 37795389

Molecular Mechanisms of Hormones Implicated in Migraine and the Translational Implication for Transgender Patients

Overview
Date 2023 Oct 5
PMID 37795389
Authors
Affiliations
Soon will be listed here.
Abstract

Migraine is a primary headache disorder recognized by the World Health Organization as one of the most poorly understood and debilitating neurological conditions impacting global disability. Chronic pain disorders are more frequently diagnosed among cisgender women than men, suggesting that female sex hormones could be responsible for mediating chronic pain, including migraine and/or that androgens can be protective. This review discusses the major gonadal hormones, estrogens, progesterone, and testosterone in the context of molecular mechanisms by which they play a role in migraine pathophysiology. In addition, the literature to date describing roles of minor sex hormones including prolactin, luteinizing hormone, follicular stimulating hormone, and gonadotropin releasing hormone in migraine are presented. Because transgender and gender non-conforming (trans*) individuals are an underserved patient population in which gender-affirming sex hormone replacement therapy (HRT) is often medically necessary to align biological sex with gender identity, results from cisgender patient populations are discussed in the context of these major and minor sex hormones on migraine incidence and management in trans* patients.

Citing Articles

Finesse in Gender Affirming Frontal Contouring With Corrugator Resection.

Hu K, Ihnat J, Parikh N, Vassallo M, Almeida M, Alper D Aesthet Surg J Open Forum. 2025; 6:ojae108.

PMID: 40007598 PMC: 11852261. DOI: 10.1093/asjof/ojae108.


Migraine in men.

Fitzek M, Boucherie D, de Vries T, Handtmann C, Fathi H, Raffaelli B J Headache Pain. 2025; 26(1):3.

PMID: 39754046 PMC: 11697684. DOI: 10.1186/s10194-024-01936-7.


The Potential Health Risks and Benefits of Progesterone in the Transgender Woman Population-A Narrative Review.

Szymczyk S, Maczka K, Madrzak L, Grymowicz M, Smolarczyk R J Clin Med. 2024; 13(22).

PMID: 39597939 PMC: 11594581. DOI: 10.3390/jcm13226795.


How Sex Hormones Affect Migraine: An Interdisciplinary Preclinical Research Panel Review.

Godley 3rd F, Meitzen J, Nahman-Averbuch H, ONeal M, Yeomans D, Santoro N J Pers Med. 2024; 14(2).

PMID: 38392617 PMC: 10889915. DOI: 10.3390/jpm14020184.


Problems in management of medication overuse headache in transgender and gender non-conforming populations.

Martinez C, Liktor-Busa E, Largent-Milnes T Front Neurol. 2024; 15:1320791.

PMID: 38352134 PMC: 10861768. DOI: 10.3389/fneur.2024.1320791.

References
1.
Katsarava Z, Buse D, Manack A, Lipton R . Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2011; 16(1):86-92. PMC: 3258393. DOI: 10.1007/s11916-011-0233-z. View

2.
Brennan K, Romero Reyes M, Lopez Valdes H, Arnold A, Charles A . Reduced threshold for cortical spreading depression in female mice. Ann Neurol. 2007; 61(6):603-6. DOI: 10.1002/ana.21138. View

3.
Shields L, Seifert T, Shelton B, Plato B . Testosterone levels in men with chronic migraine. Neurol Int. 2019; 11(2):8079. PMC: 6589638. DOI: 10.4081/ni.2019.8079. View

4.
Gordon A, Krieger N, Okechukwu C, Haneuse S, Samnaliev M, Charlton B . Decrements in health-related quality of life associated with gender nonconformity among U.S. adolescents and young adults. Qual Life Res. 2017; 26(8):2129-2138. PMC: 5511094. DOI: 10.1007/s11136-017-1545-1. View

5.
Braidman I, Rose D . Effects of sex hormones on three glucocorticoid-inducible enzymes concerned with amino acid metabolism in rat liver. Endocrinology. 1971; 89(5):1250-5. DOI: 10.1210/endo-89-5-1250. View